3.2256

0.28% -0.009

After Hours: 3.2256

Acasti Pharma Inc (ACST)

Overview News Price History Financials Discussions Forecast Stock Split

Acasti Pharma Inc stock is currently priced at $3.2256, with a 24-hour trading volume of 11,139. It has seen a -0.28% decreased in the last 24 hours and a +15.61% rose in the past month. The chart indicates a potential bullish trend, as the stock is above the $3.22 pivot point. If it approaches the $3.29 resistance level, significant changes may occur.

Previous Close:

$3.2346

Open:

$3.25

24h Volume:

11,139

Market Cap:

$30.32M

Revenue:

Net Income/Loss:

$-38.77M

P/E Ratio:

-0.5719

EPS:

-5.64

Net Cash Flow:

$-13.57M

1W Performance:

+5.41%

1M Performance:

+15.61%

6M Performance:

+51.44%

1Y Performance:

+508.60%

1D Range:

$3.20

$3.25

52W Range:

$0.49

$3.7594

Acasti Pharma Inc Stock (ACST) Company Profile

Name

Acasti Pharma Inc

Sector

Healthcare (1204)

Industry

Biotechnology (696)

Phone

450 687 2262

Address

3009 boulevard de la Concorde East, Suite 102, Laval, QC

Employee

Twitter

@AcastiPharma

Next Earnings Date

2024-06-21

Latest SEC Filings

ACST's Discussions on Twitter

Acasti Pharma Inc Stock (ACST) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-01-20	Downgrade	Oppenheimer	Outperform → Perform
Jul-06-20	Upgrade	B. Riley FBR	Neutral → Buy
Jan-13-20	Downgrade	B. Riley FBR	Buy → Neutral
Aug-29-19	Initiated	B. Riley FBR	Buy
Jul-18-19	Initiated	Oppenheimer	Outperform
Jun-26-19	Initiated	H.C. Wainwright	Buy

View All

Acasti Pharma Inc Stock (ACST) Latest News

Acasti Pharma Inc. (NASDAQ:ACST) Sees Large Increase in Short Interest - Defense World

Defense World

Acasti Pharma (NASDAQ:ACST) Stock Passes Above Two Hundred Day Moving Average of $2.81 - Defense World

Defense World

Acasti Pharma to Attend BIO International Convention 2024 - GlobeNewswire

GlobeNewswire

Acasti Pharma to Attend BIO International Convention 2024 - Yahoo Finance UK

Yahoo Finance UK

Acasti Pharma (NASDAQ:ACST) Stock Price Crosses Below 200-Day Moving Average of $2.79 - Defense World

Defense World

Insider Stock Buying Reaches US$2.50m On Acasti Pharma - Yahoo Canada Finance

Yahoo Canada Finance

Acasti Pharma Inc Stock (ACST) Financials Data

Acasti Pharma Inc (ACST) Net Income 2024

ACST net income (TTM) was -$38.77 million for the quarter ending December 31, 2023, a -124.83% decrease year-over-year.

Acasti Pharma Inc (ACST) Cash Flow 2024

ACST recorded a free cash flow (TTM) of -$13.57 million for the quarter ending December 31, 2023, a +13.79% increase year-over-year.

Acasti Pharma Inc (ACST) Earnings per Share 2024

ACST earnings per share (TTM) was -$4.5778 for the quarter ending December 31, 2023, a -242.75% decline year-over-year.

Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.